¿Qué son las revisiones sistemáticas?Cochrane2026-11-17 | ¿Qué son las revisiones sistemáticas?An introduction from Dr Karla Soares-WeiserCochrane2025-10-02 | New Cochrane CEO, Dr Karla Soares-Weiser, shares her vision for the future of Cochrane and calls for collaboration to produce an evidence ecosystem that is fast, fair and fit for the future.Cochrane Classmate in a nutshellCochrane2025-09-03 | ...An introduction to Cochrane CrowdCochrane2025-07-30 | Got a burning passion for health and ready to make a difference? We’ve got you covered.
Cochrane Crowd (http://crowd.cochrane.org) is an online citizen science platform that enables anyone with an interest in health to contribute to health evidence. Our volunteers make it easier for health researchers to find the latest, high-quality evidence on what treatments work and don’t work. This means health practitioners can more easily access current evidence to inform the treatments they provide. Just a few minutes each day makes a huge difference. This video introduces Cochrane Crowd, and how you can get involved.Cochrane Crowd Virtual TourCochrane2025-07-30 | ...Tracking your progress in Cochrane CrowdCochrane2025-07-30 | ...Pathways in Cochrane CrowdCochrane2025-07-30 | ...Module 4: Synthesising the evidenceCochrane2025-07-30 | Module 4 in our short series on key steps involved in producing a systematic review. This final video is about the important step in producing a systematic review known as synthesising the evidence!Module 3: Assessing the evidenceCochrane2025-07-30 | Module 3 in our short series on key steps involved in producing a systematic review. This brief video is all about the importance of assessing the studies you have found for your systematic review.Module 2: Finding the evidenceCochrane2025-07-30 | Module 2 in our short series on key steps involved in producing a systematic review. This brief video is all about finding the evidence for your systematic review.Module 1: Asking the right questionCochrane2025-07-30 | Module 1 in our short series on key steps involved in producing a systematic review. This brief video is all about making sure the question is right!Building the Future of Science Together: Transparency, Engagement & Impact | Cochrane x SaSCochrane2025-02-12 | Join Ana Beatriz Pizarro (Cochrane) and Camilla Arvidsson (Sense about Science) for a discussion on the future of science. This webinar explores the importance of evidence transparency, public engagement, and impact in research. Learn how you can get involved with the Cochrane Early Career Professionals network and Sense about Science, contribute to science communication, and support evidence-based decision-making.Cochrane’s Future of Evidence Synthesis Programme: A TransformationCochrane2025-01-15 | The arrival of 2025 means that we are now wrapping up our Future of Evidence Synthesis Programme, with several projects now closed and a few more due to wrap up by April 2025. All aspects of the programme were designed to ensure that Cochrane is well-placed to meet rapidly shifting needs and challenges in global healthcare. It has been an ambitious programme that has introduced some important changes to how Cochrane develops, publishes, and shares its reviews.Cochrane Journal Club - Priority Setting ExerciseCochrane2024-12-03 | Topic discussed: Priority Settings Case: Selection of PICO questions for planification of Cochrane reviews in the Cochrane MS groupIntroduction to Cochrane Thematic GroupsCochrane2024-12-03 | ...Introduction to Cochrane Evidence Synthesis UnitsCochrane2024-11-25 | ...Cochrane Annual General Meeting 2024Cochrane2024-11-15 | Some highlights of interest: 0:00 - Welcome from Dr Susan Phillips, Chair of the Governing Board 02:03 - Agenda 03:09 - Report from the Chair 14:20 - Report from the Treasurer 22:06 - Report from the Chief Executive Officer 32:44 - Report from the Editor in Chief 45:16 - Member's Questions 1:02:19 - Awards and Prizes 1:11:40 - Voting Results
If you have any questions following reviewing AGM content, please email agm@cochrane.orgWinner of the 2024 Chris Silagy Prize: Richard MorleyCochrane2024-11-14 | Dr Chris Silagy was the founding Director of the Australasian Cochrane Centre and instrumental in Cochrane's development and success. Chris was energetic, positive and inspiring. Before his death in December 2001, Chris expressed a wish for a Fund to be established, to be held by the Monash Foundation. Chris initiated this fund with his own contribution, and requested donations be made to it instead of flowers or other tributes after his death.
Chris requested that this Fund be used to recognise contributions to Cochrane in ways that are often insufficiently recognised; for example, providing administration, management, Colloquium organisation, communication and motivation - in short, the 'glue' that helps to keep Cochrane together.
The Chris Silagy Prize is given to an individual who has made an extraordinary contribution to Cochrane, made a contribution that exceeds the expectations of their employment, made a contribution to Cochrane that would not be recognised outside the scope of this Prize, and has been identified by their peers as consistently contributing to a spirit of collaboration.
The 2023 Chris Silagy Prize winner is Richard Morley.
Learn more here: community.cochrane.org/news/winner-2024-chris-silagy-prize-richard-morleyWinner of the 2024 Kenneth Warren Award: Shaun LeeCochrane2024-11-14 | Kenneth Warren was an enthusiastic supporter of the pilot work in pregnancy and childbirth that led to the creation of The Cochrane Collaboration, and, with Fred Mosteller, he co-organized the meeting at the New York Academy of Sciences at which the vision for Cochrane was first made public.
The Kenneth Warren Prize is awarded every year by Cochrane to a scientist who publishes a Cochrane Review about a health issue in developing countries. The winning entry judged to be both of high methodological quality and relevant to health problems in low-income countries.
The 2024 Kenneth Warren Award goes to Shaun Lee, for "Interventions for people with type 2 diabetes mellitus fasting during Ramadan."
Learn more here: community.cochrane.org/news/winner-2024-kenneth-warren-award-shaun-leeWinner of the 2024 Anne Anderson Award: Rachelle BuchbinderCochrane2024-11-14 | Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care. A clinically qualified reproductive physiologist, Anne had an active interest in women’s health, co-editing the first edition of Women’s Problems in General Practice with Ann McPherson and contributed to Effectiveness and Satisfaction in Antenatal Care (1982), edited by Murray Enkin and Iain Chalmers. She was discussing with Marc Keirse and Iain Chalmers the possibility of co-editing a companion volume on elective birth, however her premature death from breast cancer in 1983 ended her involvement. Iain Chalmers, Murray Enkin and Marc Keirse went on to publish Effective Care in Pregnancy and Childbirth (ECPC) in 1989, dedicating the book in part to Anne. ECPC, through its systematic approach to assessing the research literature, is widely acknowledged to have led to the development of Cochrane.
The goal of the Anne Anderson Award is to recognize and stimulate individuals contributing to the enhancement of women’s visibility and participation in Cochrane’s leadership. In the footsteps of Anne Anderson, many outstanding women continue to contribute and inspire other women to improve health knowledge for the good of their communities. The Award recipient designates the cash award to assist another woman from a low-resource setting with her own Cochrane activities.
The 2024 Anne Anderson Award goes to Rachelle Buchbinder.
Intro to GRADE - Carotid artery stenosis and Stroke
- Methodology discussed - Intro to GRADE. - Clinical Case - Elderly patient with stroke due to carotid artery stenosis - Clinical Question - Which definitive neuro-surgical procedure (based on a Cochrane meta-analysis) best suits our patient. Is it carotid stenting vs endarterectomy?Interested in writing a Cochrane review? We have a wide range of resources for prospective authorsCochrane2024-06-05 | Writing a Cochrane review can seem daunting, especially for new authors. So, you’ll be glad to know that Cochrane offers a comprehensive suite of tools and resources that everyone can access at no cost.
cochrane.org/join-cochrane/become-cochrane-authorSwitching to Cochranes new Focused Review Format: what you need to knowCochrane2024-03-12 | Cochrane has made significant changes and improvements to Cochrane’s review production model, which has led to the creation of our new focused review format. This isn't just a tweak - it's a complete overhaul to make life easier for our authors and improve how our systematic reviews are conducted and presented.
- Welcome from Tiffany Duque - #InspireInclusion in health: What is the first step? from Dr Luis Gabriel Cuervo Amore - #WomeninScience Strategies to Call to Action from Dr Vivian Welch - Mentee & Mentor: different languages, different cultures, and how to foster inclusion together from Kehinde Ayomide Agubosim and Dr Karen Gibbs - Questions and Closure from Paola Andrenacci
Special thanks to Moderators Maya Abdelwahab, Claudia De Santis, and Julia Costs-Maria Carolina Isaza.
#iwd2024 #internationalwomensday2024The Cochrane US Global Health Equity Mentoring programCochrane2024-03-04 | The Cochrane US Global Health Equity Mentoring program was developed in 2021 and is currently in Year 3 (2023-2024). The program is designed for health science and evidence enthusiasts across the globe who meet equity criteria such as living in a low-resource or historically marginalized setting, experience discrimination and health inequity, and students and professionals who have lacked access to evidence-based healthcare curricula, experts, and materials.
In this video, you will hear from a subset of Year 1, 2, and 3 mentees, who will highlight some of their favourite program accomplishments completed with their mentors, fellow mentees, and others in Cochrane.
To learn more, visit the Cochrane US website: us.cochrane.orgMaking health decisions: whats best for you?Cochrane2024-02-14 | This webinar hosted by Cochrane UK was held with patients and doctors reflecting on their experiences and some important things to consider when making health decisions.
Link to the video 'A life-changing health decision: Sarah's story': youtu.be/E0-u3v6iSlo?si=LnjA_r4r68zfY9tZPatient Intervention Comparator Outcome (PICO) FrameworkCochrane2024-02-14 | Video by Sarah Tanveer
In this video, Sarah explains what PICO(TS) stands for and provides examples of review questions.
This video won first place in Cochrane UK's 2018 Cochrane Colloquium video competition.From complexity to clarity: real-world performance of an accessible poster templateCochrane2024-01-31 | ISMPP EU 2024 Poster walkthrough.
cochrane.org/news/complexity-clarity-research-shows-benefit-betterposter-templates-cochrane-colloquiumA life-changing health decision: Sarahs storyCochrane2024-01-18 | Sarah Chapman, a former nurse with a long career in health research, had progressive hearing loss since early adulthood. Recently she was faced with a life changing decision if she would like to go ahead with an optional cochlear implant. In this video with illustrations by Karen Morley, Sarah talks us through her personal story of healthcare decision making and how evidence and other factors fit into her thinking.
Learn about the resources available to you: cochrane.org/news/making-health-decisions-sarahs-storyInternational Volunteer Day 2023: thank you to all our volunteers!Cochrane2023-12-05 | This International Volunteer Day, 5 December, Cochrane's Chief Executive Catherine Spencer has recorded a message to thank all of our volunteers.
In 2023, nearly 4,000 people earnt Cochrane membership through volunteering have translated over 3 million words into different languages, screened over a million records in Cochrane Crowd and contributed in countless other ways.
To find out more about the volunteering opportunities available at Cochrane, visit cochrane.org/join-cochrane/contributeBuilding trust through co creation: re-imagining evidenceCochrane2023-10-06 | Generating evidence through the combination of scientific and lived experience has the potential to enable mutual trust between research and society. The aim of this session is to spark a lively discussion about addressing the impact of experiential knowledge and through that, building deeper understandings and relationships between researchers, research participants and people involved. In this session, we explore why information and evidence as we know it may not be enough to support decision making, and reflect on examples that demonstrate ways to build trust and co-create evidence, with a discussion of differences as well as mutual learnings in the global south and global north.
Keynotes: 3:36 - Building Trust: Challenging division (Peter Beresford) 16:13 - Co-creating Engagement and Evidence, Globally (Bella Starling) 31:45 - From TB to COVID and Back Again: Community Engagement for Essential Evidence (Tasha Koch) 45:48 - Using Creative and Participatory Methods to Research Prioritisation in Primary Care (Shoba Dawson)
This session was chaired by Richard Morley, Cochrane’s Consumer Engagement Officer and Maureen Smith, Chair of Cochrane Consumer Network Executive.
1:27:32 - One of Cochrane’s annual prizes was presented at the end of the session. Chris Silagy Prize
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordingsForward together for trusted evidence: 2023 Cochrane LectureCochrane2023-10-04 | Given the ever-growing potential for misinformation and disinformation in an interconnected world, the need for trusted evidence has never been greater. As we navigate a post-COVID-19 pandemic world, evolving data and technological opportunities, and the reality of change, ensuring that the evidence that informs health and care decisions is timely, trusted and relevant will be an ongoing challenge. This Cochrane Lecture explores a framework for sustaining and promoting trusted evidence that not only withstands scrutiny but actively guides informed decision-making by addressing emerging needs through a continuous feedback loop between evidence producers and users. The lecture emphasises the importance of the interlinked pillars of relevance, equity, integrity, transparency, and rigour underpinned by collaboration between stakeholders and researchers as we journey forward together embracing diverse perspectives, experience and expertise to co-produce and deliver evidence that is not only trusted but makes a difference for patients and the public globally.
Prsented by Yemisi Takwoingi
-1:04:15 - Cochrane’s annual prizes and awards were presented at the end of the session. - 1:05:00 - Bill Silverman Prize - 1:07:32 - Thomas Chalmers Awards - 1:12:18 - Closing thanks and remarks
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordingsHow Cochrane responded to the need for evidence on new diagnostic tests during the Covid-19 pandemicCochrane2023-10-04 | During the Covid-19 pandemic there was a need for timely, unbiased, informative and accurate evidence on new diagnostic tests.
In mid-March 2020, leaders in Cochrane put out a call for help to provide evidence to assist decision-making during the emerging pandemic. On 26th March 2020, we formed the Cochrane Covid Diagnostic Test Accuracy Group – an international group of methodologists, test accuracy specialists, statisticians, epidemiologists and clinicians committed to deliver a portfolio of reviews to provide and maintain a reliable evidence base on which test policies could be based.
In the following days, Cochrane published two Cochrane Diagnostic Test Accuracy Protocols (on days 29 and 68) and five Cochrane Diagnostic Test Accuracy systematic reviews (on days 91, 103, 153, 189 and 239) reporting on the accuracy of antibody tests, signs and symptoms, rapid antigen and molecular tests, imaging tests, and routine laboratory tests. Since then, Cochrane has published eight updates of these reviews, and a further four reviews are close to being completed. To date, these five reviews have been cited 3375 times, and used in 22 international guidelines.
Completing these reviews has involved: recruiting over 100 researchers on a voluntary basis from more than 14 countries across six continents; developing new methods to deal with the magnitude of papers, use of pre-prints and new data sources; adapting protocols as knowledge and understanding developed; identifying and engaging with stakeholders (including the World Health Organization (WHO), the Foundation for Innovative New Diagnostics (FIND) and the Cochrane Infectious Diseases group) to ensure the reviews were informative and addressed relevant questions; and developing working arrangements across Cochrane to enable timely publication, including rapid peer review, editorial support and fixing software challenges. Our approach exemplifies Cochrane’s principles of collaboration, enthusiasm, avoiding duplication of effort, and minimizing bias whilst striving for clinical relevance, quality, open access and avoiding all conflicts of interest.
This session introduces the story of the team’s approach and work. We highlight the findings of the reviews, discuss the challenges and solutions we found in working in a new and moving area of health and technology, and discuss how we tried to make sure our findings had impact.
Speakers - 2:08 - Context, strategy and outcomes - Jon Deeks, University of Birmingham - 18:37 - Signs and symptoms to determine if a patient presenting in primary care of hospital outpatient settings has COVID-19 - Ann Van den Bruel, KU Leuven - 28:00 - Tension between policy and emerging evidence - Jac Dinnes, University of Birmingham - 39:40 - Cochrane 'living' systematic review on diagnostic accuracy of imaging for COVID-19 - Nayaar Islam - 47:56 - Review question evolution: Diagnosis to Prognosis - Mariska Leeflang, Amsterdam UMC, University of Amsterdam - 47:56 - Information Retrieval - Rene Spijker, Cochrane Netherlands - 1:07 - Fiona Lethbridge, Science Media Centre - 1:14:30 - Michael Brown, Michigan State University - 1:17:56 - Questions from the audience
Chaired by Toby Lasserson, Cochrane Central Executive Team
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordings#CochraneLondon - Ensuring integrity in biomedical researchCochrane2023-10-02 | We all need data we can trust. Cochrane policy requires that studies with serious research integrity problems, including fraudulent data, be excluded from Cochrane Reviews. This plenary explores the scope and root causes of the problem of fraudulent and problematic research. Solutions to identifying and preventing the publication of research with serious research integrity problems were discussed. The international panel of speakers offered perspectives from a variety of disciplines on paper mills, tools to identify fraudulent studies, and what systematic reviewers and journals can do to improve research integrity.
Keynotes: - 5:14 - Quantity over quality: a primer on research paper mills (Jenny Byrne) - 14:06 - Journals identifying and eliminating problem studies (John Carlisle) - 24:25 - This is a global issue: The African Research Integrity Network (ARIN) (Limbanazo Matandika) - 33:53 - How to reduce structural and academic incentives that promote fraud (Cyril Labbe) - 42: 03 - Protecting the integrity of systematic reviews (Lisa Bero)
This session was chaired by Richard Van Noorden, from Nature.
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordings#CochraneLondon - 30 Years of the Cochrane CollaborationCochrane2023-10-02 | As we celebrate 30 years since the founding of the Cochrane Collaboration, Karla Soares-Weiser and Jimmy Volmink discuss with some of the founders of the Collaboration what motivated them and others who co-founded the organization. Karla and Jimmy are joined by Iain Chalmers, Muir Gray and Jini Hetherington among others in this look back at the formation of the Collaboration in 1993. Answers to a range of questions explore the collaborative ethos that inspired the creation of a global network to prepare and maintain systematic reviews of research to inform decisions in health care.
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordings#CochraneLondon - Global health, equity and trustCochrane2023-10-02 | An important goal of global health is to advance health equity for all people worldwide. Trust in global health research, practice and policy is crucial for achieving this goal. In this plenary we start by examining the historical roots of mistrust in global health, citing examples of research abuses and barriers to the delivery of care in marginalised communities. This is followed by a discussion of challenges for evidence generation, synthesis and use encountered during the COVID-19 pandemic. Next, we shift our focus to the impact of the profit motive on trust and equity in health and offer guidance on the conduct of systematic reviews focussing on the commercial determinants of health. We conclude by providing recommendations for improving research integrity and building trust in global health research.
Keynotes:
- 6:00 - Why trust is an important issue in global health (Jimmy Volmink) - 21:45 - How COVID broke the evidence pipeline (Helen Pearson) - 36:16 - Commercial determinants of health: influence of private sector activities on evidence and equity (Mark Petticrew) - 53:12 - Building trust in (global) health research (Gowri Gopalakrishna)
The session was chaired by Cochrane’s Editor-in-Chief, Karla Soares-Weiser and Eva Madrid from Cochrane Chile.
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordingsTransferring content to the Central Editorial Service Next stepsCochrane2023-10-02 | The second webinar on transferring editorial content was held on Thursday 28 September and was intended for Cochrane Review Group editorial staff who will be responsible for transferring editorial content to the Central Editorial Service.A focused review of study centric data – why and what’s new?Cochrane2023-09-27 | Over the past 30 years Cochrane has grown as a global network with a reputation for producing gold standard evidence syntheses. At the same time, the biomedical publishing field has grown too. We are making some big changes in 2023 to confirm our place as one of the world’s leaders in producing trusted health and social care evidence.
Reviews will be shorter. Users of evidence are best served by a more focused article, which also makes writing and updating them simpler. The main body of the review will contain sections that are most useful to users of Cochrane evidence, with a clearer distinction between the main article and supplementary materials. With a shorter review we are moving the structure to where it’s needed most: the data. This change is powered by moving to study centric data in RevMan. By improving the structure of data associated with Cochrane reviews, we can increase their impact by making it easier for policy makers, guideline developers and others to reuse our evidence.
In this webinar, Ella Flemyng (Interim Head of Editorial Policy and Research Integrity) and Gert van Valkenhoef (Head of IT Infrastructure and Development) will discuss these developments and the benefits for authors and users of Cochrane reviews.Moving towards a new model - the role of Cochrane Review Groups, question and answer Session 1Cochrane2023-09-22 | The way Cochrane produces systematic reviews is changing and a big part of that change is the centralization of the editorial process for all Cochrane Reviews. A significant number of Cochrane Reviews Groups closed following the end of NIHR funding in the UK, however many are continuing to operate as we develop new structures and ways of working. Continuing CRGs will play a vital role over the next few years, as changes are rolled out.
This series of meetings provides an opportunity for CRG staff to discuss their role and particularly to understand what tasks they can continue to do, and those tasks that will eventually be managed by the Central Editorial Service.
Hear from Ruth Foxlee, Karla Soares-Weiser, Toby Lasserson, France Kellie, Ursula Gonthier.
Q&A from 14 August Session 1Moving towards a new model - the role of Cochrane Review Groups, question and answer Session 2Cochrane2023-09-22 | The way Cochrane produces systematic reviews is changing and a big part of that change is the centralization of the editorial process for all Cochrane Reviews. A significant number of Cochrane Reviews Groups closed following the end of NIHR funding in the UK, however many are continuing to operate as we develop new structures and ways of working. Continuing CRGs will play a vital role over the next few years, as changes are rolled out.
This series of meetings provides an opportunity for CRG staff to discuss their role and particularly to understand what tasks they can continue to do, and those tasks that will eventually be managed by the Central Editorial Service.
Hear from Ruth Foxlee, Karla Soares-Weiser, Toby Lasserson, France Kellie, Ursula Gonthier.
Q&A from 14 August Session 2Moving towards a new model - the role of Cochrane Review Groups, question and answer Session 3Cochrane2023-09-22 | The way Cochrane produces systematic reviews is changing and a big part of that change is the centralization of the editorial process for all Cochrane Reviews. A significant number of Cochrane Reviews Groups closed following the end of NIHR funding in the UK, however many are continuing to operate as we develop new structures and ways of working. Continuing CRGs will play a vital role over the next few years, as changes are rolled out.
This series of meetings provides an opportunity for CRG staff to discuss their role and particularly to understand what tasks they can continue to do, and those tasks that will eventually be managed by the Central Editorial Service.
Hear from Ruth Foxlee, Karla Soares-Weiser, Toby Lasserson, France Kellie, Ursula Gonthier.
Q&A from 24 August Session 3Moving towards a new model - the role of Cochrane Review Groups, question and answer Session 4Cochrane2023-09-22 | The way Cochrane produces systematic reviews is changing and a big part of that change is the centralization of the editorial process for all Cochrane Reviews. A significant number of Cochrane Reviews Groups closed following the end of NIHR funding in the UK, however many are continuing to operate as we develop new structures and ways of working. Continuing CRGs will play a vital role over the next few years, as changes are rolled out.
This series of meetings provides an opportunity for CRG staff to discuss their role and particularly to understand what tasks they can continue to do, and those tasks that will eventually be managed by the Central Editorial Service.
Hear from Ruth Foxlee, Karla Soares-Weiser, Toby Lasserson, France Kellie, Ursula Gonthier.
Q&A from 14 August Session 4Cochrane AGM 2023 SlidesCochrane2023-09-15 | Video of the AGM available at youtu.be/Kp8kDWi1ZBg 00:00 Welcome and introduction to the Trustees 04:25 Co-Chairs' Report 12:45 Treasurer's Report 23:25 Council Report 27:08 Chief Executive Officer Report 38:10 Editor in Chief of the Cochrane Library Report 50:28 Members' Questions and Any Other Business 1:03:13 Anne Anderson Award 1:06:35 Kenneth Warren Prize 1:09:26 Emeritus and Lifetime AwardsCochrane Annual General Meeting 2023Cochrane2023-09-15 | Video with slides available at youtu.be/iD1UyOeCHZg 00:00 Welcome and introduction to the Trustees 04:25 Co-Chairs' Report 12:45 Treasurer's Report 23:25 Council Report 27:08 Chief Executive Officer Report 38:10 Editor in Chief of the Cochrane Library Report 50:28 Members' Questions and Any Other Business 1:03:13 Anne Anderson Award 1:06:35 Kenneth Warren Prize 1:09:26 Emeritus and Lifetime Membership Awards 1:13:20 Date of Next Annual General Meeting
Watch other recordings from #CochraneLondon 2023: events.cochrane.org/colloquium-2023/recordingsCochrane: 30 years of evidenceCochrane2023-09-07 | Cochrane, a global independent network of researchers, professionals, patients, carers, and health enthusiasts is celebrating its 30th Anniversary in 2023.Cochrane Community Strategy Engagement Webinar Part 1Cochrane2023-08-08 | These webinars were set up as an opportunity for Cochrane’s Community to engage in Cochrane’s organisational strategy development process.
Catherine Spencer, Cochrane’s Chief Executive Officer, describes the draft new organisational strategy, takes question from the meeting participants and explains further opportunities for Cochrane’s Community to send feedback on the draft organisational strategyCochrane Community Strategy Engagement Webinar Part 2Cochrane2023-08-08 | These webinars were set up as an opportunity for Cochrane’s Community to engage in Cochrane’s organisational strategy development process.
Catherine Spencer, Cochrane’s Chief Executive Officer, describes the draft new organisational strategy, takes question from the meeting participants and explains further opportunities for Cochrane’s Community to send feedback on the draft organisational strategyCochrane Evidence Synthesis and Methods: Transferring content to the Central Editorial ServiceCochrane2023-08-04 | This session was held in July 2023 for Cochrane Review Group editorial staff who are responsible for transferring editorial content to the Central Editorial Service.
The editorial process for all Cochrane protocols, reviews and updates will be managed centrally by the Central Editorial Service by the end of March 2024. This webinar provided a brief overview of the Central Editorial Service’s editorial process and summarised all the milestones and timelines for the transfer of content to the Central Editorial Service, with a focus on the process involved in the first two milestones:
Step 1: Transfer of open invitations with a submission deadline later than 31 August 2023;
Step 2: All new protocols, reviews, and updates where the first draft is submitted after 1 September 2023 are transferred to the Central Editorial Service as soon as the submissions come in.Cochrane Q&A: Changes ahead & what they mean for authorsCochrane2023-04-04 | Hear from the Project Leads on changes ahead with questions from the audience on: • Moving fully to RevMan Web • How Cochrane Reviews are changing this yearIWD: Message from Dr Zoia RazumovaCochrane2023-03-20 | Dr Zoia Razumova, Vice Chair of The European Network of Young Gynae Oncologists.
Learn more about Cochrane's IWD events here: cochrane.org/news/cochranes-2023-international-womens-day-event-recording-availableCochrane Evidence Synthesis and Methods: A new Cochrane journal Q&ACochrane2023-03-16 | In November 2022, submissions opened for Cochrane Evidence Synthesis and Methods, Cochrane’s first open-access journal. In this webinar, Michael Brown, Editor of Cochrane Evidence Synthesis and Methods, and Ella Flemyng, Editorial Product Lead in Cochrane, discuss why we launched a journal, what its aim is, and how people across the community can get involved.
This webinar was part of Cochrane’s Future of Evidence Synthesis webinar series.